Cargando…

Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking

The selectivity of drugs for G protein-coupled receptor (GPCR) signaling pathways is crucial for their therapeutic efficacy. Different agonists can cause receptors to recruit effector proteins at varying levels, thus inducing different signaling responses, called signaling bias. Although several GPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dongxue, Yao, Yunjin, Wang, Shiqi, Hou, Yifei, Zhao, Lanxue, Wang, Hao, Chen, Hongzhuan, Xu, Jianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138654/
https://www.ncbi.nlm.nih.gov/pubmed/37108518
http://dx.doi.org/10.3390/ijms24087356
_version_ 1785032758388588544
author Wang, Dongxue
Yao, Yunjin
Wang, Shiqi
Hou, Yifei
Zhao, Lanxue
Wang, Hao
Chen, Hongzhuan
Xu, Jianrong
author_facet Wang, Dongxue
Yao, Yunjin
Wang, Shiqi
Hou, Yifei
Zhao, Lanxue
Wang, Hao
Chen, Hongzhuan
Xu, Jianrong
author_sort Wang, Dongxue
collection PubMed
description The selectivity of drugs for G protein-coupled receptor (GPCR) signaling pathways is crucial for their therapeutic efficacy. Different agonists can cause receptors to recruit effector proteins at varying levels, thus inducing different signaling responses, called signaling bias. Although several GPCR-biased drugs are currently being developed, only a limited number of biased ligands have been identified regarding their signaling bias for the M1 muscarinic acetylcholine receptor (M1mAChR), and the mechanism is not yet well understood. In this study, we utilized bioluminescence resonance energy transfer (BRET) assays to compare the efficacy of six agonists in inducing Gαq and β-arrestin2 binding to M1mAChR. Our findings reveal notable variations in agonist efficacy in the recruitment of Gαq and β-arrestin2. Pilocarpine preferentially promoted the recruitment of β-arrestin2 (∆∆RAi = −0.5), while McN-A-343 (∆∆RAi = 1.5), Xanomeline (∆∆RAi = 0.6), and Iperoxo (∆∆RAi = 0.3) exhibited a preference for the recruitment of Gαq. We also used commercial methods to verify the agonists and obtained consistent results. Molecular docking revealed that certain residues (e.g., Y404, located in TM7 of M1mAChR) could play crucial roles in Gαq signaling bias by interacting with McN-A-343, Xanomeline, and Iperoxo, whereas other residues (e.g., W378 and Y381, located in TM6) contributed to β-arrestin recruitment by interacting with Pilocarpine. The preference of activated M1mAChR for different effectors may be due to significant conformational changes induced by biased agonists. By characterizing bias towards Gαq and β-arrestin2 recruitment, our study provides insights into M1mAChR signaling bias.
format Online
Article
Text
id pubmed-10138654
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101386542023-04-28 Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking Wang, Dongxue Yao, Yunjin Wang, Shiqi Hou, Yifei Zhao, Lanxue Wang, Hao Chen, Hongzhuan Xu, Jianrong Int J Mol Sci Article The selectivity of drugs for G protein-coupled receptor (GPCR) signaling pathways is crucial for their therapeutic efficacy. Different agonists can cause receptors to recruit effector proteins at varying levels, thus inducing different signaling responses, called signaling bias. Although several GPCR-biased drugs are currently being developed, only a limited number of biased ligands have been identified regarding their signaling bias for the M1 muscarinic acetylcholine receptor (M1mAChR), and the mechanism is not yet well understood. In this study, we utilized bioluminescence resonance energy transfer (BRET) assays to compare the efficacy of six agonists in inducing Gαq and β-arrestin2 binding to M1mAChR. Our findings reveal notable variations in agonist efficacy in the recruitment of Gαq and β-arrestin2. Pilocarpine preferentially promoted the recruitment of β-arrestin2 (∆∆RAi = −0.5), while McN-A-343 (∆∆RAi = 1.5), Xanomeline (∆∆RAi = 0.6), and Iperoxo (∆∆RAi = 0.3) exhibited a preference for the recruitment of Gαq. We also used commercial methods to verify the agonists and obtained consistent results. Molecular docking revealed that certain residues (e.g., Y404, located in TM7 of M1mAChR) could play crucial roles in Gαq signaling bias by interacting with McN-A-343, Xanomeline, and Iperoxo, whereas other residues (e.g., W378 and Y381, located in TM6) contributed to β-arrestin recruitment by interacting with Pilocarpine. The preference of activated M1mAChR for different effectors may be due to significant conformational changes induced by biased agonists. By characterizing bias towards Gαq and β-arrestin2 recruitment, our study provides insights into M1mAChR signaling bias. MDPI 2023-04-16 /pmc/articles/PMC10138654/ /pubmed/37108518 http://dx.doi.org/10.3390/ijms24087356 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Dongxue
Yao, Yunjin
Wang, Shiqi
Hou, Yifei
Zhao, Lanxue
Wang, Hao
Chen, Hongzhuan
Xu, Jianrong
Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title_full Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title_fullStr Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title_full_unstemmed Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title_short Structural Insights into M1 Muscarinic Acetylcholine Receptor Signaling Bias between Gαq and β-Arrestin through BRET Assays and Molecular Docking
title_sort structural insights into m1 muscarinic acetylcholine receptor signaling bias between gαq and β-arrestin through bret assays and molecular docking
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138654/
https://www.ncbi.nlm.nih.gov/pubmed/37108518
http://dx.doi.org/10.3390/ijms24087356
work_keys_str_mv AT wangdongxue structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT yaoyunjin structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT wangshiqi structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT houyifei structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT zhaolanxue structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT wanghao structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT chenhongzhuan structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking
AT xujianrong structuralinsightsintom1muscarinicacetylcholinereceptorsignalingbiasbetweengaqandbarrestinthroughbretassaysandmoleculardocking